Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray for sedation in painless fiberoptic bronchoscopy
ChiCTR2400092233Phase 4Not yet recruiting
- Sponsor
- Guangxi Medical University Second Affiliated Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in bronchopulmonary diseases (3 arms), sponsored by Guangxi Medical University Second Affiliated Hospital. Primary endpoints: Sedative effect, Respiratory function and 1 more. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2400092233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092233.